Aliases & Classifications for Angiomatosis

About this section
Sources:
49NINDS, 50Novoseek, 68UMLS
See all MalaCards sources

Aliases & Descriptions for Angiomatosis:

Name: Angiomatosis 49 50 68

Summaries for Angiomatosis

About this section
NINDS:49 Von Hippel-Lindau disease (VHL) is a rare, genetic multi-system disorder in which non-cancerous tumors grow in certain parts of the body. Slow-growing hemgioblastomas -- benign tumors with many blood vessels -- may develop in the brain, spinal cord, the retinas of the eyes, and near the inner ear. Cysts (fluid-filled sacs) may develop around the hemangioblastomas. Other types of tumors develop in the adrenal glands, the kidneys, or the pancreas. Symptoms of VHL vary among individuals and depend on the size and location of the tumors. Symptoms may include headaches, problems with balance and walking, dizziness, weakness of the limbs, vision problems, deafness in one ear, and high blood pressure. Individuals with VHL are also at a higher risk than normal for certain types of cancer, especially kidney cancer.

MalaCards based summary: Angiomatosis is related to hemopneumothorax and hypomelanosis of ito. An important gene associated with Angiomatosis is VHL (Von Hippel-Lindau Tumor Suppressor), and among its related pathways is PI3K-Akt signaling pathway. Affiliated tissues include brain, kidney and retina, and related mouse phenotypes are Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection and endocrine/exocrine gland.

Wikipedia:71 Angiomatosis is a non-neoplastic condition presenting with little knots of capillaries in various... more...

Related Diseases for Angiomatosis

About this section

Diseases related to Angiomatosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 141)
idRelated DiseaseScoreTop Affiliating Genes
1hemopneumothorax29.5IFNA2, VHL
2hypomelanosis of ito28.4FLT4, GALNT3, GLMN, GYS1, IFNA2, PROX1
3bacillary angiomatosis12.2
4diffuse dermal angiomatosis12.2
5skeletal-extraskeletal angiomatosis11.9
6breast angiomatosis11.9
7familial capillaro-venous leptomeningeal angiomatosis11.9
8angiomatosis, leptomeningeal capillary venous11.8
9sturge-weber syndrome, somatic, mosaic11.8
10angiomatosis, diffuse corticomeningeal, of divry and van bogaert11.8
11cystic angiomatosis of bone, diffuse11.7
12cobb syndrome11.2
13bartonellosis11.1
14gorham's disease11.0
15von hippel-lindau syndrome11.0
16multiple enchondromatosis, maffucci type10.7
17multifocal lymphangioendotheliomatosis with thrombocytopenia10.7
18multiple mitochondrial dysfunctions syndrome 110.2CCL26, TSC2
19blue color blindness10.2CD4, IFNA2
20fallopian tube adenofibroma10.2GNAQ, IFNA2
21stromal corneal pigmentation10.2CD4, IFNA2
22retinitis10.2
23weber syndrome10.1
24facial nerve disease10.1GNAQ, IFNA2
25sarcoma10.1
26hydronephrosis10.1ATR, CD4, CERKL
27lysteria monocytoigeneses meningitis10.1FLT4, PROX1
28oculodentodigital dysplasia10.1FLT4, PROX1
29chromosome 18 pericentric inversion10.1FLT4, PROX1
30cat-scratch disease10.0
31acrofacial dysostosis, patagonia type10.0FLT4, PROX1
32benign familial neonatal epilepsy10.0FLT4, IFNA2, PROX1
33weyers ulnar ray/oligodactyly syndrome10.0FLT4, GLMN, GNAQ
34acquired immunodeficiency syndrome10.0
35ovarian brenner tumor9.9FLT4, IFNA2, TSC2, VHL
36cerebritis9.9
37keratosis follicularis spinulosa decalvans9.9FLT4, PROX1
38saethre-chotzen syndrome9.9CD4, FLT4, IFNA2
39leukemia9.9
40thrombocytopenia9.9
41meningitis9.9
42atherosclerosis9.8
43hepatitis9.8
44bacteremia9.8
45chronic lymphocytic leukemia9.8
46mediastinitis9.8
47endotheliitis9.8
48kaposi sarcoma9.7
49cervicitis9.7
50calciphylaxis9.7

Graphical network of the top 20 diseases related to Angiomatosis:



Diseases related to angiomatosis

Symptoms & Phenotypes for Angiomatosis

About this section

GenomeRNAi Phenotypes related to Angiomatosis according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00233-A-310.0CCL26, FLT4, MED12, PROX1

MGI Mouse Phenotypes related to Angiomatosis according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053798.7ATR, CD4, GALNT3, GNAQ, PLAG1, PROX1
2MP:00053808.7ATR, DLK1, FLT4, GLMN, MED12, PLAG1
3MP:00053708.7ATR, DLK1, FLT4, GYS1, PROX1, TSC2
4MP:00028738.0ATR, CD4, FLT4, GNAQ, MED12, PROX1
5MP:00053847.9ATR, CD4, CERKL, DLK1, GLMN, GYS1
6MP:00053857.4ATR, DLK1, FLT4, GALNT3, GLMN, GNAQ
7MP:00053767.2ATR, CD4, DLK1, FLT4, GALNT3, GLMN
8MP:00053786.4ATR, CD4, DLK1, FLT4, GALNT3, GLMN

Drugs & Therapeutics for Angiomatosis

About this section

Drugs for Angiomatosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 43)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Sirolimusapproved, investigationalPhase 2, Phase 3194053123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
2
EverolimusapprovedPhase 2, Phase 31940159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
Zortress
everolimus
3
Miconazoleapproved, investigational, vet_approvedPhase 2, Phase 3370622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
4Anti-Bacterial AgentsPhase 2, Phase 311226
5Immunosuppressive AgentsPhase 2, Phase 313086
6Antibiotics, AntitubercularPhase 2, Phase 37180
7Antifungal AgentsPhase 2, Phase 33696
8Anti-Infective AgentsPhase 2, Phase 322062
9Pharmaceutical SolutionsPhase 2, Phase 3, Phase 18192
10
RanibizumabapprovedPhase 1, Phase 2486347396-82-1459903
Synonyms:
347396-82-1
D05697
Lucentis
Lucentis (TN)
 
Ranibizumab
Ranibizumab (USAN/INN)
Ranibizumab (genetical recombination)
Ranibizumab (genetical recombination) (JAN)
ranibizumab
rhuFab V2
11
Sunitinibapproved, investigationalPhase 2, Phase 1510341031-54-7, 557795-19-45329102
Synonyms:
(2S)-2-hydroxybutanedioic acid
1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)
1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)
326914-13-0
341031-54-7
5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE
557795-19-4
AC1NS62J
AC1O5CMQ
AKOS005145765
Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)
CHEBI:38940
CHEBI:550864
CHEMBL1567
CHEMBL535
CID5329102
CID6456015
D06402
D08552
DB01268
DB07417
EN002687
FT-0083555
FT-0083556
I01-1229
K00588a
KS-5022
LS-186078
LS-187023
LS-187648
MolPort-003-986-763
N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate
N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
NCGC00164631-01
 
NSC736511
NSC750690
PDGF TK antagonist
PHA-290940AD
PNU-290940AD
S1042_Selleck
ST51053712
SU 011248
SU 11248
SU-010398
SU-011248 L-malate salt
SU-11248
SU-11248 L-malate salt
SU-11248J
SU-12662
SU010398
SU011248
SU011248 L-malate salt
SU11248
Su-011248
Sunitanib
Sunitinib
Sunitinib (INN)
Sunitinib (free base)
Sunitinib malate
Sunitinib malate (JAN/USAN)
Sunitinib malate [USAN]
Sunitinibum
Sutent
Sutent (TN)
Sutent, SU-11248
TL8002546
UNII-LVX8N1UT73
UNII-V99T50803M
sunitinib
sunitinibum
12
SomatostatinapprovedPhase 223738916-34-6, 51110-01-153481605
Synonyms:
growth hormone-inhibiting hormone (GHIH)
 
somatotropin release-inhibiting factor (SRIF)
somatotropin release-inhibiting hormone
13
PancrelipaseapprovedPhase 297053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
PA
 
Pancreatic alpha-amylase precursor
Pancrelipase (amylase
lipase
protease)
14
VatalanibinvestigationalPhase 240212141-54-3151194
Synonyms:
1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine succinate
CGP79787
PTK 787
 
PTK/ZK
PTK787
PTK787/ZK 222584
ZK222584
vatalanib
15Angiogenesis Modulating AgentsPhase 2, Phase 1, Early Phase 14185
16Angiogenesis InhibitorsPhase 2, Phase 1, Early Phase 14257
17RadiopharmaceuticalsPhase 2514
18Fluorodeoxyglucose F18Phase 2412
19Protein Kinase InhibitorsPhase 23689
20AnticonvulsantsPhase 1, Phase 22695
21pancreatinPhase 2970
22histidineNutraceuticalPhase 1, Phase 245
23
Bevacizumabapproved, investigationalPhase 1, Early Phase 12020216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
24
TimololapprovedPhase 125226839-75-833624, 5478
Synonyms:
(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
(2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-timolol
131628-37-0
194288-09-0
26839-75-8
26921-17-5 (maleate (1:1) salt)
AB00513729
AC1L1PYN
AC1Q59QM
Apo-Timol
Apo-Timop
Aquanil
BIDD:GT0073
BPBio1_001008
BRD-K08806317-050-03-6
BSPBio_000916
Betim
Betimol
Betimol (TN)
Blocadren
C07141
C13H24N4O3S
CAS-26921-17-5
CHEBI:9599
CHEMBL499
CID33624
CPD001456519
D08600
DB00373
DB08625
EINECS 248-032-6
HMS2089I11
HSDB 6533
Istalol
L-714,465
LS-122231
Lopac-T-6394
Lopac0_001189
MK-950
NCGC00016038-01
 
NCGC00016038-02
NCGC00016798-01
NCGC00016798-07
NCGC00022033-02
NCGC00022033-04
NCGC00022033-05
Novo-Timol
Nu-Timolol
Oprea1_640981
Optimol
Phoxal-timolol
Prestwick0_000948
Prestwick1_000948
Prestwick2_000948
Prestwick3_000948
Proflax
S(-)-Timolol maleate
S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
SAM002564238
SPBio_003075
ST072193
TIM
Temserin
Tenopt
Tim-AK
Timacar
Timacor
Timolol
Timolol (INN)
Timolol (TN)
Timolol GFS
Timolol Maleate, (1:1) Salt
Timolol [USAN]
Timolol anhydrous
Timolol maleate
Timololo
Timololum
Timololum [INN-Latin]
Timopic
Timoptic
Timoptic OcuDose
Timoptic in Ocudose
Timoptic-XE
Timoptol
Tocris-0649
UNII-817W3C6175
timolol
25
Vorinostatapproved, investigationalPhase 1247149647-78-95311
Synonyms:
149647-78-9
1zz1
AC-1923
AC1L1K2K
BRD-K81418486-001-10-3
C111237
CCRIS 8456
CHEBI:45716
CHEMBL98
CID5311
D06320
DB02546
EC-000.2057
FT-0082592
LS-186548
LS-186997
LS-187780
MK-0683
MK0683
MLS001065855
Merck brand of Vorinostat
MolPort-003-850-293
N'-hydroxy-N-phenyloctanediamide
N-Hydroxy-N'-phenyl octanediamide
N-Hydroxy-N'-phenyloctanediamide
N-Hyrdroxy-N'-phenyloctanediamide
N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide
N-hydroxy-N'-phenyloctanediamide
N1-hydroxy-N8-phenyloctanediamide
NCGC00168085-02
 
NHNPODA
NSC-701852
NSC701852
OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE
Octanedioic acid hydroxyamide phenylamide
S1047_Selleck
SAHA
SAHA cpd
SAHA, Suberoylanilide hydroxamic acid
SHH
SKI390
SMR000486344
SW-064652
Suberanilohydroxamic acid
SuberoylaN/Aide hydroxamic acid
Suberoylanilide hydroxamic acid
UNII-58IFB293JI
Vorinostat
Vorinostat (JAN/USAN)
Vorinostat MSD
Vorinostat [USAN]
Vorinostatum
WIN64652
ZINC01543873
Zolinza
Zolinza (TN)
Zolinza, MK-0683, SAHA
m344
nchembio.275-comp2
nchembio.313-comp1
nchembio815-comp18
suberoylanilide hydroxamic acid
26
Maleic acidexperimentalPhase 1296110-16-7444266
Synonyms:
(2Z)-2-Butenedioate
(2Z)-2-Butenedioic acid
(2Z)-Butene-2-dioate
(2Z)-Butene-2-dioic acid
(2Z)-but-2-enedioate
(2Z)-but-2-enedioic acid
(Z)-2-Butenedioate
(Z)-2-Butenedioic acid
(z)-butenedioate
(z)-butenedioic acid
2-Butenedioate
2-Butenedioic acid
Cis-butenedioate
Cis-butenedioic acid
 
H2male
Kyselina maleinova
MAE
Maleate
Maleic acid
Maleic acid [NA2215]
Maleinic acid
Malenic acid
Malezid CM
Scotchbond multipurpose etchant
Toxilic acid
cis-1,2-Ethylenedicarboxylic acid
cis-2-Butenedioate
cis-2-Butenedioic acid
cis-But-2-enedioate
cis-But-2-enedioic acid
27ImmunoglobulinsPhase 16394
28Antibodies, MonoclonalPhase 14039
29AntibodiesPhase 16394
30Neurotransmitter AgentsPhase 118340
31TetrahydrozolinePhase 1621
32Ophthalmic SolutionsPhase 11140
33Adrenergic AntagonistsPhase 11573
34Lubricant Eye DropsPhase 1168
35Adrenergic beta-AntagonistsPhase 11193
36Anti-Arrhythmia AgentsPhase 13093
37Antihypertensive AgentsPhase 14207
38Adrenergic AgentsPhase 15352
39Histone Deacetylase InhibitorsPhase 1569
40Mitogens1617
41Endothelial Growth Factors382
42Dermatologic Agents5806
43GTPase-Activating Proteins1

Interventional clinical trials:

(show all 41)
idNameStatusNCT IDPhase
1Trial of Sirolimus for Cognitive Impairment in Sturge-Weber SyndromeRecruitingNCT03047980Phase 2, Phase 3
2Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) DiseaseCompletedNCT01168440Phase 2
3Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584CompletedNCT00052013Phase 2
4Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related MaculopathyCompletedNCT00470977Phase 1, Phase 2
5Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber SyndromeCompletedNCT02080624Phase 2
6Phase II Study of Vandetanib in Individuals With Kidney CancerCompletedNCT00566995Phase 2
717AAG to Treat Kidney Tumors in Von Hippel-Lindau DiseaseCompletedNCT00088374Phase 2
8A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist RanibizumabRecruitingNCT02859441Phase 1, Phase 2
9PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell CarcinomaRecruitingNCT03108066Phase 2
10Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine TumorsRecruitingNCT01967537Phase 2
11Pazopanib in Von Hippel-Lindau (VHL) SyndromeActive, not recruitingNCT01436227Phase 2
12Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber SyndromeActive, not recruitingNCT02332655Phase 1, Phase 2
13TKI 258 in Von Hippel-Lindau Syndrome (VHL)TerminatedNCT01266070Phase 2
14Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau SyndromeTerminatedNCT00673816Phase 1, Phase 2
15Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to FollowTerminatedNCT00330564Phase 2
16Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)WithdrawnNCT01997255Phase 2
17EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau SyndromeCompletedNCT00056199Phase 1
18Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau SyndromeCompletedNCT00089765Phase 1
19Use of the Atkins Diet for Children With Sturge Weber SyndromeCompletedNCT00639730Phase 1
20Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical TimololRecruitingNCT01533376Phase 1
21Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)Enrolling by invitationNCT02108002Phase 1
22Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous HemangiomasCompletedNCT00374335
23Hemangioma Associated With High Rates of MorbidityCompletedNCT00394888
24Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac TumorsCompletedNCT00001668
25Biomarker Development in Sturge-Weber SyndromeCompletedNCT01345305
26Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau DiseaseCompletedNCT00970970
27Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)CompletedNCT00610402
28Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau SyndromeCompletedNCT00075348
29Registry for Vascular Anomalies Associated With CoagulopathyRecruitingNCT00576888
30Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) PatientsRecruitingNCT02420067
31Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau DiseaseRecruitingNCT00062166
32Familial Investigations of Childhood Cancer PredispositionRecruitingNCT03050268
33Lymphatic Anomalies RegistryRecruitingNCT02399527
34National Eye Institute Biorepository for Retinal DiseasesRecruitingNCT01496625
35Innovative Approaches to Gauge Progression of Sturge-Weber SyndromeRecruitingNCT01425944
36Von Hippel-Lindau Disease Genetic Epidemiology StudyActive, not recruitingNCT00001803
37Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl SystemActive, not recruitingNCT02120040
38French National Cohort of Children With Port Wine StainActive, not recruitingNCT01364857
39Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau DiseaseActive, not recruitingNCT00005902
40Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?Enrolling by invitationNCT02207686
41Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau DiseaseTerminatedNCT01015300Early Phase 1

Search NIH Clinical Center for Angiomatosis

Genetic Tests for Angiomatosis

About this section

Anatomical Context for Angiomatosis

About this section

MalaCards organs/tissues related to Angiomatosis:

36
Brain, Kidney, Retina, Spinal cord, Eye, Adrenal gland, Pancreas

Publications for Angiomatosis

About this section

Articles related to Angiomatosis:

(show top 50)    (show all 545)
idTitleAuthorsYear
1
Obscure Overt Gastrointestinal Bleeding Due To Isolated Small Bowel Angiomatosis. (27144197)
2016
2
Bacillary angiomatosis presenting with facial tumor and multiple abscesses: A case report. (27428207)
2016
3
Diffuse Dermal Angiomatosis of the Breast With an Apparent Etiology of Underlying Calcified Thrombosed Artery With Adjacent Fat Necrosis. (27097335)
2016
4
Bacillary angiomatosis presenting with polymorphic skin lesions. (27752473)
2016
5
Bullous erythema ab igne with cutaneous reactive angiomatosis. (27226050)
2016
6
Endothelial chimerism in chronic sclerotic-type chronic Graft-versus-Host disease and GVHD-associated angiomatosis. (26875995)
2016
7
Angiomatosis dAcrmica difusa de la mama: aportaciA^n de un nuevo caso en paciente no fumadora. (27617469)
2016
8
Graft-versus-host Disease-associated Angiomatosis Treated With Topical Timolol Solution. (27191176)
2016
9
Successful treatment of bacillary angiomatosis with oral doxycycline in an HIV-infected child with skin lesions mimicking Kaposi sarcoma. (27051835)
2016
10
Persistent cutaneous abdominal ulcerations secondary to diffuse dermal angiomatosis: an underestimated sign for severe atherosclerosis: A case report. (27442644)
2016
11
Diffuse Dermal Angiomatosis: A Clue to the Diagnosis of Atherosclerotic Vascular Disease. (26120304)
2015
12
Imaging features of systemic cystic angiomatosis. (26141486)
2015
13
Cutaneous bacillary angiomatosis due to Bartonella quintana in a renal transplant recipient. (25652715)
2015
14
Diffuse dermal angiomatosis of the abdomen. (26066057)
2015
15
Diffuse dermal angiomatosis associated with severe atherosclerosis: two cases and review of the literature. (25639294)
2015
16
Bacillary Angiomatosis in Immunocompetent Patient with Atypical Manifestations. (26538736)
2015
17
Diffuse dermal angiomatosis: a clinical mimicker of vasculitis associated with calciphylaxis and monoclonal gammopathy. (25502367)
2015
18
Mediastinal angiomatosis: a rare case report. (26793386)
2015
19
Diffuse dermal angiomatosis of the breast: a series of 22 cases from a single institution. (26645009)
2015
20
Leptomeningeal Angiomatosis in a Case of Neurofibromatosis Type 2: An Unusual Finding. (26510155)
2015
21
Pneumothorax-associated fibroblastic lesion in combination with localized pleural angiomatosis: A possible cause of juvenile spontaneous hemopneumothorax. (25749626)
2015
22
Bacillary angiomatosis presenting as a digital ulcer. (25994885)
2015
23
Bacillary angiomatosis: A rare finding in the setting of antiretroviral drugs. (26636153)
2015
24
Vaginal angiomatosis: differential diagnosis of a rare case. (26401116)
2015
25
Wyburn-Mason Syndrome Associated With Cutaneous Reactive Angiomatosis and Central Retinal Vein Occlusion. (26247458)
2015
26
Letter to the Editor Regarding Sturge-Weber Syndrome (Encephalotrigeminal Angiomatosis): Recent Advances and Future Challenges. (26147014)
2015
27
Pulmonary manifestation of a condition resembling Kasabach-Merritt syndrome in a woman with abdominal angiomatosis associated with consumptive coagulopathy--surgical management: a case report. (25956942)
2015
28
Angiomatosis: A Rare Vascular Proliferation of Head and Neck Region. (26157312)
2015
29
Diffuse Breast Angiomatosis With Involvement ofA Overlying Skin: A Case Report. (26456034)
2015
30
Bacillary Angiomatosis Masquerading as Kaposi Sarcoma in East Africa. (24718378)
2014
31
Bacillary angiomatosis in a HIV-positive patient with poor adherence to antiretroviral therapy. (25580791)
2014
32
Mediastinal angiomatosis. (25193206)
2014
33
Diffuse angiomatosis of the breast--sonographic appearance. (24965677)
2014
34
Cutaneovisceral angiomatosis with thrombocytopenia without cutaneous involvement. (25088066)
2014
35
Tumoral bacillary angiomatosis in a child with human immunodeficiency virus. (25076357)
2014
36
A case of bacillary angiomatosis in a patient with pancreatic adenocarcinoma. (24588271)
2014
37
Sturge-Weber Syndrome (Encephalotrigeminal Angiomatosis): Recent Advances and Future Challenges. (26107979)
2014
38
Bacillary angiomatosis. (25187668)
2014
39
Propranolol for cerebral cavernous angiomatosis: a magic bullet. (23804539)
2014
40
Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity. (24993601)
2014
41
Cutaneous reactive angiomatosis with foreign body reaction after total knee replacement with a defective implant: a diagnostic challenge with a review of the literature. (24635713)
2014
42
Diffuse dermal angiomatosis: a contributory factor to ulceration in a patient with renal transplant. (25265928)
2014
43
Dental management in an encephalotrigeminal angiomatosis patient: a case report. (25284546)
2014
44
Diffuse dermal angiomatosis of the breast: Clinicopathologic study of 5 patients. (25264238)
2014
45
Cystic bone angiomatosis: a case report treated with aminobisphosphonates and review of the literature. (23836156)
2013
46
Bacillary Angiomatosis in Patients With Cancer: A Pediatric Case Report and a Review of the Literature. (26619465)
2013
47
Angiomatosis of the thoracic wall. (21773787)
2013
48
Cutaneous reactive angiomatosis associated with erythema ab igne. (24266664)
2013
49
Progressive late-onset of cutaneous angiomatosis as possible sign of cerebral cavernous malformations. (23473272)
2013
50
Multi-system progressive angiomatosis in a dog resembling blue rubber bleb nevus syndrome in humans. (23496103)
2013

Variations for Angiomatosis

About this section

Expression for genes affiliated with Angiomatosis

About this section
Search GEO for disease gene expression data for Angiomatosis.

Pathways for genes affiliated with Angiomatosis

About this section

Pathways related to Angiomatosis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
18.6FLT4, GYS1, IFNA2, TSC2

GO Terms for genes affiliated with Angiomatosis

About this section

Biological processes related to Angiomatosis according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of interleukin-2 biosynthetic processGO:004508610.4CD4, GLMN
2lymph vessel developmentGO:000194510.3FLT4, PROX1
3lymphangiogenesisGO:000194610.3FLT4, PROX1
4neural tube closureGO:000184310.2GLMN, MED12, TSC2
5positive regulation of endothelial cell proliferationGO:000193810.1CCL26, FLT4, PROX1
6heart developmentGO:00075079.5GNAQ, GYS1, MED12, TSC2
7positive regulation of transcription, DNA-templatedGO:00458939.0CD4, IFNA2, MED12, PROX1, VHL

Sources for Angiomatosis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet